National Account Director
Revolution Medicines
National Account Director
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Senior Director, Provider Accounts, the National Account Director, Community Oncology (NAD) is responsible for establishing and maintaining strategic relationships to secure optimal market access for our innovative oncology medicines with Group Purchasing Organizations (GPO), key community oncology stakeholders and provider-driven clinical pathways. The NAD will develop and execute account plans and strategies that drive rapid pathway and protocol inclusions to support rapid access while representing the company's interests with key decision-makers. The NAD will help to coordinate cross-functional workstreams to ensure products are included when appropriate in provider-driven clinical pathways. This is a field-based remote position.
Key Responsibilities:
Translate national, brand-level strategy to key accounts across community oncology key stakeholders and group purchasing organizations (GPOs).
Lead and oversee account activities such as driving rapid, clinical pathway and treatment protocol inclusion post launch in close collaboration with Medical Affairs.
Lead all Business to Business and C-Suite relationships with key accounts to support speaker programs, access activities and company partnerships.
Build and maintain strong KOL and C-level relationships with aligned GPO and large aggregator accounts.
Lead cross-functional team across commercial Field to pro-actively identify and resolve access barrier issues.
Track and Analyze business opportunities to proactively provide strategic and tactical guidance.
Negotiate favorable contracts and agreements in alignment with strategic business objectives.
Champion voice of customer to internal stakeholders and commercial leadership.
Provide strategic insights and feedback to brands, field, and market access.
Create medium to long term strategic engagement plan spanning multiple product and indication launches and focuses on engaging beyond transactional approaches.
Facilitate executive exchanges to create opportunities for Rev Med leaders and GPO/Large Account C-Suite leaders to meet and align.
Consistently strong appropriate engagement with GPO, GPO account filed-based managers, Aggregator Account leadership and formulary decision makers.
Proactively communicate when important opportunities arise.
Activate resources to support opportunities and challenges.
Ability to design and lead pull through projects with commercial field.
Conduct quarterly business reviews with key systems and internal stakeholders.
Required Skills, Experience and Education:
Bachelor’s degree required.
10+ years’ progressive experience in strategic account management.
Strong established relationships within community oncology GPOs and the C-level leadership at large oncology clinics.
Demonstrated understanding of reimbursement, economic flows, and oral oncolytic trends within group purchasing organization key customer stakeholders.
Strong communication skills to educate and influence other stakeholders, including the commercial executive leadership team and US Market Access.
Ability to clearly and efficiently communicate the value proposition of novel oncology therapies to customers.
Excellent negotiation skills and strategic alignment with enterprise P&L objectives.
Prior experience with pipeline products and product launches.
Ability to partner effectively with Medical Affairs, Sales, Marketing and Field Reimbursement teams.
50% travel required to customer meetings, industry conferences, and RevMed’s home office in Redwood City, CA.
Preferred Skills:
Advanced degree (MBA, Master’s, PharmD, PhD).
Comprehensive experience and understanding of community GPOs and the clinic market.
Experience in GI oncology, PDAC and/or NSCLC, including oral targeted therapies.
Successful coordination of leadership exchanges and strategic partnerships beyond traditional contracting and rebate agreements.
Previous oncology launch experience.
Proved ability to stay abreast of the evolving healthcare landscape.
Expertise in establishing high-functioning, collaborative relationships with new and rapidly growing teams.
Prior people leadership experience and ability to build team as company grows.
#LI-SS2 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 245000 - 290000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines